Published in N Engl J Med on February 21, 2002
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol (2011) 2.59
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant (2012) 2.46
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol (2009) 2.27
Induced immune tolerance for kidney transplantation. N Engl J Med (2011) 2.08
A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft. Kidney Int (2015) 2.02
Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med (2013) 1.68
The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol (2009) 1.48
Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A (2009) 1.47
Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol (2010) 1.31
Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am J Pathol (2006) 1.26
Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int (2003) 1.19
An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol (2009) 1.17
Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol (2008) 1.15
Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) (2008) 1.15
Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation. PLoS One (2010) 1.14
Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol (2008) 1.11
Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol (2009) 1.11
Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism. Curr Opin Organ Transplant (2011) 1.10
Cadaver transplantation in Recent Era: Is Cadaveric Graft Survival Similar to Living Kidney Transplantation? Int J Organ Transplant Med (2011) 1.07
Similar outcomes among black and white renal allograft recipients. J Am Soc Nephrol (2008) 1.07
Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol (2008) 1.06
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients. J Exp Med (2007) 1.04
Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy. Blood (2009) 1.03
Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One (2009) 1.03
Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol (2008) 1.03
Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy (2011) 1.02
Is delayed graft function causally associated with long-term outcomes after kidney transplantation? Instrumental variable analysis. Transplantation (2013) 1.00
Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol Med (2012) 0.97
Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement. Am J Transplant (2013) 0.96
Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study. Nephrol Dial Transplant (2012) 0.94
Quantitative MR measures of intrarenal perfusion in the assessment of transplanted kidneys: initial experience. Acad Radiol (2009) 0.93
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks. Br J Clin Pharmacol (2014) 0.92
Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression. PLoS One (2012) 0.92
Composite tissue allotransplantation of the face: Decision analysis model. Can J Plast Surg (2007) 0.91
Long-term follow-up of kidney transplant recipients: comparison of hospitalization rates to the general population. Transplant Res (2013) 0.90
Subgroup analyses in randomized controlled trials: the need for risk stratification in kidney transplantation. Am J Transplant (2009) 0.89
Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study. J Transl Med (2013) 0.87
The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept. Biologics (2007) 0.87
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients. Br J Clin Pharmacol (2010) 0.86
Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation. Drug Des Devel Ther (2010) 0.84
Seizure treatment in transplant patients. Curr Treat Options Neurol (2012) 0.84
Prolonged, low-dose anti-thymocyte globulin, combined with CTLA4-Ig, promotes engraftment in a stringent transplant model. PLoS One (2013) 0.83
Streptavidin suppresses T cell activation and inhibits IL-2 production and CD25 expression. Cytokine (2012) 0.83
Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience. Clin Exp Nephrol (2010) 0.82
Urine free light chains as a novel biomarker of acute kidney allograft injury. Clin Transplant (2013) 0.82
Use of antioxidants to prevent cyclosporine a toxicity. Toxicol Res (2010) 0.82
Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program. J Nephropathol (2014) 0.82
Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study. PLoS One (2013) 0.81
Applications of translational bioinformatics in transplantation. Clin Pharmacol Ther (2011) 0.81
Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials. Clin Exp Immunol (2013) 0.81
Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism. Transplantation (2013) 0.80
Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance. Curr Opin Organ Transplant (2015) 0.80
Effector mechanisms of rejection. Cold Spring Harb Perspect Med (2013) 0.79
Kidney transplant in diabetic patients: modalities, indications and results. Diabetol Metab Syndr (2009) 0.79
Transplantation tolerance: Clinical potential of regulatory T cells. Self Nonself (2011) 0.79
De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction? J Transplant (2012) 0.78
Antiviral treatment for chronic hepatitis B in renal transplant patients. World J Hepatol (2015) 0.78
Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation. Transplant Direct (2016) 0.77
Gazing into a crystal ball to predict kidney transplant outcome. J Clin Invest (2010) 0.77
Challenges and considerations in diagnosing the kidney disease in deteriorating graft function. Transpl Int (2012) 0.77
Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. Wien Klin Wochenschr (2006) 0.77
Comparison of early and late conversion of sirolimus in experimental model of chronic cyclosporine nephropathy. J Korean Med Sci (2012) 0.76
SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection. Cell Mol Immunol (2012) 0.76
Induction of tolerance in clinical kidney transplantation. Clin Transplant (2010) 0.76
The impact of acute rejection in kidney transplantation on long-term allograft and patient outcome. Nephrourol Mon (2015) 0.76
Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability. Ther Clin Risk Manag (2009) 0.76
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients. Clin J Am Soc Nephrol (2012) 0.76
Cellular immune profile of kidney transplant patients developing anti-HLA antibodies during childhood. Pediatr Nephrol (2015) 0.76
Induced regulatory T cells in allograft tolerance via transient mixed chimerism. JCI Insight (2016) 0.75
Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy. PLoS One (2013) 0.75
Strategies to improve outcomes after renal transplantation. N Engl J Med (2002) 0.75
Five-year follow-up after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft nephropathy. Int J Clin Exp Med (2015) 0.75
Effect of mycophenolate mofetil on progression of interstitial fibrosis and tubular atrophy after kidney transplantation: a retrospective study. BMJ Open (2014) 0.75
Limited immune tolerance induced by transient mixed chimerism. Korean J Intern Med (2015) 0.75
The association between atorvastatin administration and plasma total homocysteine levels in renal transplant recipients. J Nephropathol (2016) 0.75
Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3-mediated therapeutics. Sci Rep (2017) 0.75
Strategies to improve outcomes after renal transplantation. N Engl J Med (2002) 0.75
The short-term impact of protocol biopsies in a live-related renal transplant program using tacrolimus based immunosuppression. Indian J Nephrol (2013) 0.75
Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach. Sci Rep (2017) 0.75
Individualized immunosuppression in transplant patients: potential role of pharmacogenetics. Pharmgenomics Pers Med (2012) 0.75
Strategies to improve outcomes after renal transplantation. N Engl J Med (2002) 0.75
Outcomes of Late Corticosteroid Withdrawal after Renal Transplantation in Patients Exposed to Tacrolimus and/or Mycophenolate Mofetil: Meta-Analysis of Randomized Controlled Trials. Int J Organ Transplant Med (2011) 0.75
Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients. J Immunol Res (2015) 0.75
Beneficial effect of conversion to belatacept in kidney-transplant patients with a low glomerular-filtration rate. Case Rep Transplant (2014) 0.75
Renal clear cell carcinoma emerging in a transplanted kidney 3 years after return to dialysis. Case report and review of the literature. NDT Plus (2009) 0.75
Using Home Spirometry for Follow up of Lung Transplant Recipients: "A Pilot Study". Tanaffos (2013) 0.75
Hypertension in dialysis and kidney transplant patients. Can J Cardiol (2009) 0.75
Longitudinal Serum Creatinine Levels in Relation to Graft Loss Following Renal Transplantation: Robust Joint Modeling of Longitudinal Measurements and Survival Time Data. Nephrourol Mon (2016) 0.75
Donor and recipient genetic variants in NLRP3 associate with early acute rejection following kidney transplantation. Sci Rep (2016) 0.75
Risk Stratification for Rejection and Infection after Kidney Transplantation. Clin J Am Soc Nephrol (2015) 0.75
A case of late kidney allograft failure: a clinical pathological conference from American Society of Nephrology Kidney Week 2011. Clin J Am Soc Nephrol (2012) 0.75
Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study. Transplant Direct (2016) 0.75
Strategies to improve outcomes after renal transplantation. N Engl J Med (2002) 0.75
Local graft irradiation for kidney allograft rejection: a case series and review of the literature. Nephrourol Mon (2014) 0.75
Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients. PLoS One (2016) 0.75
Antibody-mediated rejection in young kidney transplant recipients: the dilemma of noncompliance and insufficient immunosuppression. Pediatr Nephrol (2014) 0.75
Strategies to improve outcomes after renal transplantation. N Engl J Med (2002) 0.75
Estimating glomerular filtration rate in kidney transplantation: Still searching for the best marker. World J Nephrol (2015) 0.75
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant (2004) 2.45
Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol (2011) 2.17
Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial. Am J Transplant (2005) 2.08
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol (2006) 2.00
Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med (2011) 1.97
Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg (2007) 1.90
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol (2002) 1.84
Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation (2004) 1.82
Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation (2002) 1.75
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int (2011) 1.73
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int (2002) 1.72
Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol (2005) 1.71
Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis (2011) 1.55
Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant (2004) 1.54
Liver transplantation for malignancy. Oncologist (2005) 1.54
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52
Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver Transpl (2008) 1.50
Clinical role of the renal transplant biopsy. Nat Rev Nephrol (2012) 1.46
A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation (2003) 1.41
Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant (2010) 1.39
Promotion of altruistic donation. Transplantation (2009) 1.33
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2013) 1.29
Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation. Liver Transpl (2002) 1.27
Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation (2010) 1.25
Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation (2004) 1.22
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation (2003) 1.19
Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int (2005) 1.17
Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes (2012) 1.17
Immuno-intervention for the induction of transplantation tolerance through mixed chimerism. Semin Immunol (2011) 1.12
Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation (2011) 1.12
Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism. Curr Opin Organ Transplant (2011) 1.10
Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation (2002) 1.10
Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation (2002) 1.05
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03
Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl (2004) 1.02
Induction of tolerance through mixed chimerism. Cold Spring Harb Perspect Med (2014) 0.97
Differential effects of denileukin diftitox IL-2 immunotoxin on NK and regulatory T cells in nonhuman primates. J Immunol (2012) 0.95
Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3{beta} inhibition. J Biol Chem (2010) 0.94
The need for tolerance in pediatric organ transplantation. Pediatrics (2008) 0.92
Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg (2004) 0.91
Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation (2006) 0.91
A simple and cost-effective method for the isolation of islets from nonhuman primates. Cell Transplant (2003) 0.91
Living donor liver transplantation: how can we better protect the donors? Transplantation (2007) 0.91
Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol (2008) 0.91
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int (2006) 0.91
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? Transplantation (2005) 0.90
Extracorporeal liver support based on primary human liver cells and albumin dialysis--treatment of a patient with primary graft non-function. J Hepatol (2003) 0.88
A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation. Ann Surg (2016) 0.87
Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study. Hypertens Res (2013) 0.87
Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Transplantation (2002) 0.87
Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation (2004) 0.87
Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons. Xenotransplantation (2012) 0.87
Adults with Sotos syndrome: review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person. Am J Med Genet A (2011) 0.87
Liver transplantation--a vision realized. N Engl J Med (2012) 0.86
Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor. World J Surg Oncol (2011) 0.86
Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol (2004) 0.86
Biliary reconstruction and complications after living-donor liver transplantation. HPB (Oxford) (2009) 0.85
Mixed chimerism to induce tolerance: lessons learned from nonhuman primates. Transplant Rev (Orlando) (2009) 0.85
Psychiatric care of patients undergoing organ transplantation. Transplantation (2009) 0.85
The quest for transplantation tolerance: have we finally sipped from the cup? Sci Transl Med (2012) 0.85
Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts. Transpl Immunol (2012) 0.84
Clinical trials for induction of renal allograft tolerance. Curr Opin Organ Transplant (2015) 0.84
Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry. Transplantation (2012) 0.83
Cutaneous Aspergillus ustus in a lung transplant recipient: emergence of a new opportunistic fungal pathogen. J Heart Lung Transplant (2008) 0.83
Combined liver and kidney transplantation in a patient with sickle cell disease. Transplantation (2002) 0.83
Long-term experience with liver transplantation for hepatocellular carcinoma. J Gastroenterol (2010) 0.83
Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates. J Immunol (2011) 0.83
Induction of allograft tolerance in nonhuman primates and humans. Front Biosci (2007) 0.83
Total pancreatectomy with islet autotransplantation for chronic pancreatitis: do patients with prior pancreatic surgery have different outcomes? Am Surg (2012) 0.83
Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center. Liver Transpl (2007) 0.82
Impact of human leukocyte antigen matching in liver transplantation. Transplantation (2003) 0.82
Competition in liver transplantation: helpful or harmful? Liver Transpl (2015) 0.82
Reproduction and pregnancy in transplant recipients: current practices. Prog Transplant (2006) 0.81
Accurate, fast, and convenient measurement of glomerular filtration rate in potential renal transplant donors. Transplantation (2010) 0.81
Living donor kidney transplantation with multiple arteries: recent increase in modern era of laparoscopic donor nephrectomy. Arch Surg (2009) 0.81